Skip to content

Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.

Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications: Efficacy and Safety Outcomes.

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06617949
Enrollment
20
Registered
2024-10-01
Start date
2025-01-16
Completion date
2028-12-31
Last updated
2025-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use Disorder (SUD)

Keywords

Pain conrtrol, Substance use disorder, Parturient

Brief summary

The purpose of this study is to investigate the efficacy of three different modalities of post-operative pain control in parturient with opioid use disorders. The investigators aim to determine whether the different approach utilized show better outcomes with pain management and if there are any association with reduction of symptoms of anxiety, depression, and overall well-being.

Interventions

DRUGRegional Anesthesia

Transverse abdominal Plane(TAP) Block with long acting Exparel placed by a regional anesthesiologist.

DRUGHydromorphone Patient Controlled Analgelsic

This group will be administered epidural PCA as a modality for pain control post cesarian section

PROCEDUREEpidural local anesthetic infusion

Epidural group will receive pain control via a local anesthetic intermediate bolus infusion

Sponsors

Medical College of Wisconsin
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Inclusion criteria include being a parturient with Substance use disorder (SUD) and age 18-35

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with Change in pain assessment scores from baseline post surgeryimmediately after the study intervention and up to post op day 2Number of participants with significant change in pain assessment scores and any association with reduction of symptoms of anxiety, depression, and overall well-being.

Countries

United States

Contacts

Primary ContactMeredith Albrecht, MD, PhD
maalbrecht@mcw.edu414-805-8700
Backup ContactChristopher Fadumiye, MD
cfadumiye@mcw.edu414-805-8700

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026